Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01268124 | Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects | PHASE1 | COMPLETED | 56 | — | — | Dec 1, 2008 | Apr 1, 2009 | Dec 29, 2010 | - | — |
| Arm | Type | Description |
|---|---|---|
| Treatment | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| HTC-867 | DRUG | - |
Inclusion: 1. Men aged 20 to 45 years inclusive at screening. Sexually active men must agree to use a medically acceptable form of contraception during the study and continue it for 12 weeks after test article administration. 2. Body mass index (BMI) in the range of 17.6 to 26.4 kg/m2 and body weig...